Newsroom

26.11.2018
Octapharma receives Swissmedic approval for fibryga® to treat congenital and acquired fibrinogen deficiencies

Lachen, Switzerland – 26 November 2018 – Octapharma today announced that the Swiss Agency for Therap...

more

21.09.2018
Octapharma to invest Euro 21 million to build a new multi-use venue in Springe, Germany

Octapharma has confirmed to invest Euro 21 million to build a new multi-function facility in Sprin...

more

Career

Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities 

Annual Report 2018